Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Exposure to cannabinoids may exacerbate the psychological consequences of trauma

by Eric W. Dolan
July 30, 2018
in Psychopharmacology
(Photo credit: Sebastian Kaulitzki)

(Photo credit: Sebastian Kaulitzki)

Share on TwitterShare on Facebook
Follow PsyPost on Google News

Synthetic cannabinoids can increase depression- and anxiety-like behaviors in a rodent model of trauma, according to new research in European Neuropsychopharmacology.

“Brenda Sbarski, one of my master students, was very much interested to find out how pre-trauma exposure to cannabinoids affect the response to a traumatic event. All of our studies were conducted on rats with no prior exposure to cannabinoids (before the trauma) and she thought that this may not represent the human condition correctly,” said study author Irit Akirav of the University of Haifa.

The researchers were interested in learning whether chronic exposure to a cannabinoid receptor agonist before experiencing trauma would have a therapeutic effect or would exacerbate the negative consequences of trauma.

In their experiments, rats were administered the synthetic CB1/2 receptor agonist WIN55,212–2 for twelve days before being subjected to an inescapable electric shock.

Exposure to the cannabinoid receptor agonist enhanced fear retrieval and impaired fear extinction, and also increased immobility in a forced swimming test — behaviors that reflect anxiety and depression, respectively. But it was also found to have a therapeutic effect in a startle test.

The key finding is that “chronic exposure to drugs that activate CB1 receptors before being exposed to a traumatic event might have deleterious effects on the emotional response to the trauma (compared to subjects that were not expose to cannabinoids before the trauma),” Akirav told PsyPost.

“We need to study what happens when we administer cannabinoids after trauma exposure to subjects that were already exposed to cannabinoids before trauma exposure. Will they need a different treatment than the non pre-trauma exposed subjects?”

“The effects may be specific to CB1 receptor activation,” she added. “It could be that other cannabinoids (not directly activating the CB1 receptor) may have different (better?) effects on the response to the trauma.”

The study, “Chronic exposure to cannabinoids before an emotional trauma may have negative effects on emotional function“, was authored by Brenda Sbarski and Irit Akirav.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Psychedelic use linked to increased risk of unusual visual experiences
Ayahuasca

Study links moderate awe in psychedelic ayahuasca journeys to better well-being

June 21, 2025

A new study published in the Journal of Psychoactive Drugs suggests that while awe can be transformative during ayahuasca retreats, there’s a limit. Experiences marked by excessive vastness were linked to lower well-being, challenging assumptions about awe’s universal benefits.

Read moreDetails
Cannabis intoxication alters metabolism, but frequent users show fewer effects
Cannabis

Regular cannabis use linked to changes in brain activity regulating movement

June 20, 2025

Researchers have discovered that frequent cannabis users show reduced spontaneous brain activity in the motor cortex, and this neural suppression is tied to cannabis use severity and response speed, even though overall task performance remained comparable to non-users.

Read moreDetails
About 8% of psychedelic users report inappropriate sexual contact by guides
Psychedelic Drugs

Study links psychedelic use in illegal settings to increased psychotic and manic symptoms

June 18, 2025

New research suggests that naturalistic psychedelic use may worsen psychotic and manic symptoms when used in illegal settings. People with schizophrenia or bipolar I disorder appeared especially vulnerable to these effects, highlighting the importance of context and psychiatric background.

Read moreDetails
Some dark personality traits may help buffer against depression, new psychology research suggests
Mental Health

Psilocybin-assisted therapy linked to reduced depression in people with bipolar disorder, small study finds

June 17, 2025

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder. The treatment appeared well-tolerated, with no signs of mania or psychosis, offering cautious optimism for future bipolar depression research.

Read moreDetails
Psilocybin from “magic” mushrooms weakens the brain’s response to angry faces
Addiction

Single-dose psilocybin therapy shows promise for reducing alcohol consumption

June 15, 2025

Early results from a pilot study indicate that psilocybin-assisted therapy could be linked to lower alcohol consumption and improved psychological outcomes, though larger controlled trials are needed to determine whether the psilocybin itself is responsible for these changes.

Read moreDetails
Psilocybin appears to have a uniquely powerful relationship with nature relatedness
Neuroimaging

Psilocybin induces large-scale brain network reorganization, offering insights into the psychedelic state

June 14, 2025

A new study using high-resolution EEG reveals that psilocybin dramatically alters brain connectivity in rats. The psychedelic induced dose-dependent changes in network organization, disrupting normal patterns of neural communication and suggesting rodents may be viable models for studying altered consciousness.

Read moreDetails
Poor sleep may shrink brain regions vulnerable to Alzheimer’s disease, study suggests
Addiction

Scientists map how alcohol changes bodily sensations

June 14, 2025

A new study suggests that people who feel fewer bodily sensations while intoxicated may be at higher risk for alcohol misuse. Using bodily maps and heartbeat tasks, researchers linked internal awareness to physiological effects and subjective feelings of intoxication.

Read moreDetails
Brain chemistry imbalance revealed in violent offenders with antisocial personality disorder
LSD

Flipping two atoms in LSD turned it into a powerful treatment for damaged brain circuits

June 13, 2025

A new study introduces JRT, a modified version of LSD that promotes brain cell growth without triggering hallucinations. Researchers say this non-hallucinogenic compound could offer safer treatment options for schizophrenia and related brain disorders where psychedelics are typically contraindicated.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Exposure to heavy metals is associated with higher likelihood of ADHD diagnosis

Eye-tracking study shows people fixate longer on female aggressors than male ones

Romantic breakups follow a two-stage decline that begins years before the split, study finds

Believing “news will find me” is linked to sharing fake news, study finds

A common parasite not only invades the brain — it can also decapitate human sperm

Almost all unmarried pregant women say that the fetus resembles the father, study finds

New neuroscience research reveals brain antioxidant deficit in depression

Scientists uncover kidney-to-brain route for Parkinson’s-related protein spread

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy